Zacks Investment Research downgraded shares of MedEquities Realty Trust (NYSE:MRT) from a hold rating to a strong sell rating in a research note released on Saturday morning.

According to Zacks, “MedEquities Realty Trust, Inc. owns, develops, operates, leases and disposes healthcare properties and portfolios. It operates primarily in Texas, California, Nevada and South Carolina. MedEquities Realty Trust, Inc. is based in Nashville, Tennessee. “

A number of other equities analysts have also recently commented on MRT. ValuEngine cut MedEquities Realty Trust from a sell rating to a strong sell rating in a report on Friday, September 14th. Royal Bank of Canada set a $10.00 target price on MedEquities Realty Trust and gave the company a hold rating in a report on Sunday, August 12th. KeyCorp cut MedEquities Realty Trust from an overweight rating to a hold rating and set a $12.00 target price for the company. in a report on Wednesday, August 8th. B. Riley set a $12.00 target price on MedEquities Realty Trust and gave the company a buy rating in a report on Thursday, August 9th. Finally, Canaccord Genuity lowered their target price on MedEquities Realty Trust from $13.00 to $12.00 and set an overweight rating for the company in a report on Thursday, August 9th. Three investment analysts have rated the stock with a sell rating, three have issued a hold rating and four have assigned a buy rating to the company. The company currently has a consensus rating of Hold and a consensus price target of $12.00.

Shares of MedEquities Realty Trust stock opened at $9.86 on Friday. MedEquities Realty Trust has a 12 month low of $9.46 and a 12 month high of $12.05. The stock has a market cap of $307.79 million, a P/E ratio of 8.65 and a beta of -0.15.

MedEquities Realty Trust (NYSE:MRT) last announced its earnings results on Wednesday, August 8th. The financial services provider reported $0.10 EPS for the quarter, missing analysts’ consensus estimates of $0.30 by ($0.20). MedEquities Realty Trust had a net margin of 30.84% and a return on equity of 5.73%. The firm had revenue of $17.56 million for the quarter, compared to analysts’ expectations of $17.03 million. equities analysts anticipate that MedEquities Realty Trust will post 1.08 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Wednesday, August 29th. Shareholders of record on Wednesday, August 15th were given a $0.21 dividend. This represents a $0.84 dividend on an annualized basis and a yield of 8.52%. The ex-dividend date of this dividend was Tuesday, August 14th. MedEquities Realty Trust’s dividend payout ratio is currently 73.68%.

A number of hedge funds have recently bought and sold shares of MRT. Renaissance Technologies LLC raised its position in MedEquities Realty Trust by 36.0% in the 2nd quarter. Renaissance Technologies LLC now owns 839,800 shares of the financial services provider’s stock valued at $9,255,000 after purchasing an additional 222,500 shares in the last quarter. Sei Investments Co. raised its position in MedEquities Realty Trust by 63.0% in the 1st quarter. Sei Investments Co. now owns 303,873 shares of the financial services provider’s stock valued at $3,194,000 after purchasing an additional 117,397 shares in the last quarter. Russell Investments Group Ltd. raised its position in MedEquities Realty Trust by 10.8% in the 1st quarter. Russell Investments Group Ltd. now owns 1,165,213 shares of the financial services provider’s stock valued at $12,246,000 after purchasing an additional 113,799 shares in the last quarter. Sterling Capital Management LLC acquired a new stake in MedEquities Realty Trust in the 2nd quarter valued at about $957,000. Finally, BlackRock Inc. raised its position in MedEquities Realty Trust by 5.5% in the 2nd quarter. BlackRock Inc. now owns 1,499,494 shares of the financial services provider’s stock valued at $16,526,000 after purchasing an additional 77,884 shares in the last quarter. 90.80% of the stock is currently owned by institutional investors.

MedEquities Realty Trust Company Profile

MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.

Read More: Index Funds

Get a free copy of the Zacks research report on MedEquities Realty Trust (MRT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.